Oral β -glucan adjuvant therapy converts nonprotective Th2 response to protective Th1 cell-mediated immune response in mammary tumor-bearing mice

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Yeast beta-glucan amplifies phagocyte killing of iC3b-opsonized tumor cells via complement receptor 3-Syk-phosphatidylinositol 3-kinase pathway.

  2006cited by this paper
• Oral Delivery and Gastrointestinal Absorption of Soluble Glucans Stimulate Increased Resistance to Infectious Challenge

  2005cited by this paper
• Curative effects of combination therapy with lentinan and interleukin-2 against established murine tumors, and the role of CD8-positive T cells

  2005cited by this paper
• Rituximab therapy of lymphoma is enhanced by orally administered (1-->3),(1-->4)-D-beta-glucan.

  2005cited by this paper
• The human β‐glucan receptor is widely expressed and functionally equivalent to murine Dectin‐1 on primary cells

  2005cited by this paper
• Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages.

  2004cited by this paper
• Effects of marine beta-1,3 glucan on immune reactions.

  2004cited by this paper
• Collaborative Induction of Inflammatory Responses by Dectin-1 and Toll-like Receptor 2

  2003cited by this paper
• Immunopotentiation of intraepithelial lymphocytes in the intestine by oral administrations of beta-glucan.

  2003cited by this paper
• Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells.

  2003cited by this paper
• Faculty Opinions recommendation of Dectin-1 mediates the biological effects of beta-glucans.

  2003cited by this paper
• Orally administered β-glucans enhance anti-tumor effects of monoclonal antibodies

  2002cited by this paper
• Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma.

  2002cited by this paper
• The skewing to Th1 induced by lentinan is directed through the distinctive cytokine production by macrophages with elevated intracellular glutathione content.

  2002cited by this paper
• Immune recognition. A new receptor for beta-glucans.

  2001cited by this paper
• Th1/Th2-Balancing immunomodulating activity of gel-forming (1-->3)-beta-glucans from fungi.

  2001cited by this paper
• Immunoregulatory effects of the antitumor polysaccharide lentinan on Th1/Th2 balance in patients with digestive cancers.

  2000cited by this paper
• Polysaccharide immunomodulators as therapeutic agents: structural aspects and biologic function.

  2000cited by this paper
• PGG-glucan, a soluble beta-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates an NF-kappa B-like factor in human PMN: evidence for a glycosphingolipid beta-(1,3)-glucan receptor.

  1999cited by this paper
• Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18).

  1999cited by this paper
• Th2 subset dominance among peripheral blood T lymphocytes in patients with digestive cancers.

  1999cited by this paper
• Therapeutic intervention with complement and beta-glucan in cancer.

  1999cited by this paper
• The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells.

  1999cited by this paper
• Dietary supplementation with mushroom-derived protein-bound glucan does not enhance immune function in young and old mice.

  1998cited by this paper
• Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells.

  1996cited by this paper
• TGF-beta contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice.

  1996cited by this paper
• Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression

  1996cited by this paper
• (1→3)-β-d-Glucans as biological response modifiers: a review of structure-functional activity relationships

  1995cited by this paper
• Enhancement of cytokine production by macrophages stimulated with (1-->3)-beta-D-glucan, grifolan (GRN), isolated from Grifola frondosa.

  1994cited by this paper
• Reconstitution of Anti‐tumor Effects of Lentinan in Nude Mice: Roles of Delayed‐type Hypersensitivity Reaction Triggered by CD4‐positive T Cell Clone in the Infiltration of Effector Cells into Tumor

  1994cited by this paper
• T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-gamma and is inhibited by transforming growth factor-beta.

  1994cited by this paper
• Immunomodulating effects of polysaccharides from medicinal plants.

  1992cited by this paper
• Stimulation of human monocyte beta-glucan receptors by glucan particles induces production of TNF-alpha and IL-1 beta.

  1992cited by this paper
• Oral administration of SSG, a beta-glucan obtained from Sclerotinia sclerotiorum, affects the function of Peyer's patch cells.

  1991cited by this paper
• Alterations in proteoglycan synthesis common to healing wounds and tumors.

  1991cited by this paper
• Effect of orally administered beta-glucan on macrophage function in mice.

  1990cited by this paper
• Lysosomal enzyme release from human monocytes by particulate activators is mediated by beta-glucan inhibitable receptors.

  1987cited by this paper
• Antitumor and metastasis-inhibitory activities of lentinan as an immunomodulator: an overview.

  1987cited by this paper
• The role of beta-glucan receptors on blood and tissue leukocytes in phagocytosis and metabolic activation.

  1986cited by this paper
• Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear beta-1,3-D-glucan and other immunomodulators in murine cells.

  1985cited by this paper
• Clinical efficacy of lentinan on neoplastic diseases.

  1983cited by this paper
• Preclinical evaluation of lentinan in animal models.

  1983cited by this paper
• Cooperative role of T lymphocytes and macrophages in anti-tumor activity of mice pretreated with schizophyllan (SPG).

  1982cited by this paper
• THE EMPLOYMENT OF GLUCAN AND GLUCAN ACTIVATED MACROPHAGES IN THE ENHANCEMENT OF HOST RESISTANCE TO MALIGNANCIES IN EXPERIMENTAL ANIMALS

  1976cited by this paper

• Effect β glucan extracted from Candida albicans on pathological changes produced by Penicillium chrysogenum infection in mice

  2023cites this paper
• The Effect of Beta Glucan Extract of Saccharomyces Cerevieses on Cancer Cell Growth In vitro

  2018cites this paper
• Consumption of β-glucans to spice up T cell treatment of tumors: a review

  2018cites this paper
• The Cytogenetic Study of Soluble Beta Glucan of Sacy charomyces cerevisiae on Human Circulating Blood Lymphocytes

  2018cites this paper
• The effect of Saccharomyces cerevisiae β-glucan on proliferation, phagocytosis and cytokine production of murine macrophages and dendritic cells

  2017cites this paper
• The Immunostimulating Role of Lichen Polysaccharides: A Review

  2015cites this paper
• β-Glucans in the treatment and prevention of allergic diseases.

  2014influential citation
• Polysaccharides in Lentinus edodes: Isolation, Structure, Immunomodulating Activity and Future Prospective

  2014cites this paper
• Effect of (1→3),(1→6)-β-glucan on in vitro production of cytokines by leukocytes of patients with periodontitis.

  2012cites this paper
• Analysis of peripheral T cells and the CC chemokine receptor (CCR5) delta32 polymorphism in prostate cancer patients treated with carboxymethyl-glucan (CM-G)

  2012cites this paper
• Assessment of the modulation of photodynamic effect by β-glucan and characteristics of anti-CD7 monoclonal antibody during tumor process

  2011cites this paper
• Potentiating effect of beta-glucans on photodynamic therapy of implanted cancer cells in mice.

  2010cites this paper